Health Condition 1: J455- Severe persistent asthma
Conditions
Interventions
Intervention1: Nil: Nil
Intervention2: Nil: Nil
Sponsors
Kasturba Medical College
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with asthma (as per GINA criteria). On inhaler therapy for at least 6 months. Willing to provide informed consent. Both outpatients and inpatients of asthma.
Exclusion criteria
Exclusion criteria: Patients with other chronic respiratory diseases other than asthma. Unwilling or unable to complete questionnaire. Patients with language or psychiatric problems that would affect their ability to answer questions. Patients receiving inhalational therapy for other diseases. Patients using only oral therapy (i.e., not on inhalers).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Appropriateness of prescribed asthma treatment based on 2025 GINA guidelines, along with symptom severity. Level of adherence to asthma medication using the Morisky Medication Adherence Scale (MMAS-4) as: Good/Moderate/Low adherence. Quantitative measurement of adherence to inhalers using the TAI questionnaire, which will help classify adherence as: Good adherence/ Intermediate adherence/ Poor or non-adherence.Timepoint: Being a cross sectional observational study, the outcomes will be assessed/ estimated only at a single time interval, i.e., at baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients demonstrating correct vs. incorrect inhaler technique based on checklists for each device type (MDI, DPI, etc.).Timepoint: Being a cross sectional observational study, the outcomes will be assessed/ estimated only at a single time interval, i.e., at baseline. | — |
Countries
India
Contacts
Public ContactNamita Honnutagi
Kasturba Medical College, Manipal
Outcome results
None listed